Immunologic Monitoring in Immuno-Oncology

Author(s):  
William R. Gwin ◽  
Mary L. Disis
Nephron ◽  
1978 ◽  
Vol 22 (1-3) ◽  
pp. 208-211 ◽  
Author(s):  
M.R. Garovoy ◽  
P. Gailiunas ◽  
C.B. Carpenter ◽  
G.J. Busch

2011 ◽  
Vol 2011 ◽  
pp. 1-13 ◽  
Author(s):  
Shigeo Koido ◽  
Sadamu Homma ◽  
Akitaka Takahara ◽  
Yoshihisa Namiki ◽  
Hideo Komita ◽  
...  

Although dendritic cell (DC)- based cancer vaccines induce effective antitumor activities in murine models, only limited therapeutic results have been obtained in clinical trials. As cancer vaccines induce antitumor activities by eliciting or modifying immune responses in patients with cancer, the Response Evaluation Criteria in Solid Tumors (RECIST) and WHO criteria, designed to detect early effects of cytotoxic chemotherapy in solid tumors, may not provide a complete assessment of cancer vaccines. The problem may, in part, be resolved by carrying out immunologic cellular monitoring, which is one prerequisite for rational development of cancer vaccines. In this review, we will discuss immunologic monitoring of cellular responses for the evaluation of cancer vaccines including fusions of DC and whole tumor cell.


1998 ◽  
Vol 25 (6) ◽  
pp. 364-369
Author(s):  
W. Prohaska ◽  
M.M. Körner ◽  
W. Köster-Eiserfunke ◽  
R. Körfer ◽  
K. Kleesiek

CHEST Journal ◽  
1988 ◽  
Vol 94 (4) ◽  
pp. 834-836 ◽  
Author(s):  
Patricia K. Kotylo ◽  
Donald W. McCloskey ◽  
Ann Moriarty ◽  
Harold Halbrook

1996 ◽  
Vol 61 (2) ◽  
pp. 252-257 ◽  
Author(s):  
Larry L. Schulman ◽  
Eric K. Ho ◽  
Elaine F. Reed ◽  
Carlton McGregor ◽  
Craig R. Smith ◽  
...  

1999 ◽  
Vol 31 (4) ◽  
pp. 1812-1813 ◽  
Author(s):  
L Chatenoud ◽  
A Roche ◽  
D Lavenne ◽  
C Dubray ◽  
J.-F Bach

Sign in / Sign up

Export Citation Format

Share Document